Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 16/20 | 0.79 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.62 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.43 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3609521 | 0.88 | SCD (1.00) | SCDSCD5 | |
| SCHEMBL3606321 | 0.88 | SCD (0.80) | SCDSCD5 | |
| SCHEMBL3611429 | 0.88 | SCD (0.79) | SCDSCD5DPP4DPP8DPP9 | |
| SCHEMBL3602572 | 0.85 | SCD (0.78) | SCDSCD5DPP4DPP8DPP9 | |
| SCHEMBL3602575 | 0.84 | SCD (0.61) | SCDSCD5DPP4DPP8DPP9 | |
| SCHEMBL3599258 | 0.83 | SCD (0.54) | SCDSCD5DPP4DPP8DPP9 | |
| SCHEMBL3602987 | 0.83 | SCD (0.64) | SCDSCD5 | |
| SCHEMBL3611139 | 0.80 | SCD (0.79) | SCDSCD5 | |
| SCHEMBL3610488 | 0.79 | SCD (1.00) | SCDSCD5 | |
| SCHEMBL3891301 | 0.77 | SCD (0.55) | SCDSCD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100004245-A1 | AZACYCLOALKANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | MERCK FROSST CANADA LTD. (CA) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004245-A1 | AZACYCLOALKANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | SCD, SCD5, SREBF1 | SCD 1/4885SCD5 2/4885DPP4 876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.